Drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes: clinical and cost-effectiveness
CADTH
Record ID 32014000196
English
Authors' recommendations:
Seven non-randomized studies were identified regarding the clinical effectiveness of common drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes. No relevant cost studies were identified.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/apr-2013/RB0575%20Post%20Islet%20Cell%20Transplant%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Immunosuppression Therapy
- Immunosuppressive Agents
- Diabetes Mellitus
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.